David L. Halladay
Publications by Year
Research Areas
Bone Metabolism and Diseases, Bone health and treatments, Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation, Bone health and osteoporosis research
Most-Cited Works
- → Catabolic Effects of Continuous Human PTH (1–38) in Vivo Is Associated with Sustained Stimulation of RANKL and Inhibition of Osteoprotegerin and Gene-Associated Bone Formation(2001)429 cited
- → Effects of parathyroid hormone on Wnt signaling pathway in bone(2005)219 cited
- → The Osteoblast-specific Transcription Factor Cbfa1 Contributes to the Expression of Osteoprotegerin, a Potent Inhibitor of Osteoclast Differentiation and Function(2000)183 cited
- → Orally Bioavailable GSK-3α/β Dual Inhibitor Increases Markers of Cellular Differentiation In Vitro and Bone Mass In Vivo(2006)179 cited
- → Stimulation of Osteoprotegerin (OPG) Gene Expression by Transforming Growth Factor-β (TGF-β)(2001)142 cited
- → Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.(1994)137 cited
- → In Vivo Demonstration that Human Parathyroid Hormone 1–38 Inhibits the Expression of Osteoprotegerin in Bone with the Kinetics of an Immediate Early Gene(2000)130 cited
- → Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: An analysis by DNA microarray(2005)96 cited
- → Cloning and expression of the human gene for transaldolase. A novel highly repetitive element constitutes an integral part of the coding sequence.(1994)74 cited
- → ADAMTS-1: A Cellular Disintegrin and Metalloprotease with Thrombospondin Motifs Is a Target for Parathyroid Hormone in Bone(2000)65 cited